PNC FINANCIAL SERVICES GROUP, INC. - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 200 filers reported holding DENALI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 9.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,637
-40.4%
1,679
-14.8%
0.00%
Q2 2023$58,164
+73.4%
1,971
+35.4%
0.00%
Q1 2023$33,546
-27.7%
1,456
-12.8%
0.00%
Q4 2022$46,415
+71.9%
1,669
+85.2%
0.00%
Q3 2022$27,000
+12.5%
901
+10.1%
0.00%
Q2 2022$24,000
-11.1%
818
-2.4%
0.00%
Q1 2022$27,000
-58.5%
838
-42.3%
0.00%
Q4 2021$65,000
+6.6%
1,452
+19.9%
0.00%
Q3 2021$61,000
-16.4%
1,211
+30.4%
0.00%
Q2 2021$73,000
+40.4%
929
+1.3%
0.00%
Q1 2021$52,000
-33.3%
917
-1.1%
0.00%
Q4 2020$78,000
+136.4%
927
+0.3%
0.00%
Q3 2020$33,000
+50.0%
9240.0%0.00%
Q2 2020$22,000
+37.5%
924
+0.8%
0.00%
Q1 2020$16,000
+77.8%
917
+83.4%
0.00%
Q4 2019$9,000
+12.5%
5000.0%0.00%
Q3 2019$8,000
-20.0%
5000.0%0.00%
Q2 2019$10,000
-16.7%
5000.0%0.00%
Q1 2019$12,000
+20.0%
5000.0%0.00%
Q4 2018$10,000
-16.7%
500
-6.7%
0.00%
Q3 2018$12,000
+50.0%
536
+7.2%
0.00%
Q2 2018$8,0005000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders